Found 34 matching trials
Cologne Esophageal Response Prediction Study (CERP-Study) NA RATIONALE: The prognosis of patients with advanced esophageal cancer may be...
Show More Location
Department of General, Visceral and Cancer Surgery, University of Cologne
Learn More & Join Trial
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design PHASE2 The goal of this clinical research study is to learn which chemotherapy com...
Show More Location
UPMC Hillman Cancer Center - Radiation Oncology
Learn More & Join Trial
Exploratory Study Of The ERCC-1 Gene NA This study is for patients with advanced or stage II and III colon or recta...
Show More Location
Montefiore Medical Center - Weiler Campus
Learn More & Join Trial
Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer PHASE2 The study aims at piloting the concept of customization of chemotherapy bas...
Show More Location
King Abdul Aziz Medical City for National Guard Health Affairs
Learn More & Join Trial
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer PHASE2 RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, leucovorin calc...
Show More Location
University of South Alabama Mitchell Cancer Institute
Learn More & Join Trial
GILT Docetaxel - Non-Small Cell Lung Cancer PHASE3 Primary Objective:
* To compare response rate between genotypic groups and...
Show More Learn More & Join Trial
Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab N/A RATIONALE: Studying samples of tissue from patients with cancer in the labo...
Show More Location
Multiple Locations
Learn More & Join Trial
The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer PHASE2 The standard treatment for non-small cell lung cancer, stage IV or IIIB mal...
Show More Location
H. Lee Moffitt Cancer Center & Research Institute
Learn More & Join Trial
Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity N/A Approximately one-third of all patients treated with cisplatin develop rena...
Show More Location
Faculty of medicine, Ain Shams University
Learn More & Join Trial
Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer PHASE2 In recent years, treatment of advanced pancreatic cancer is changing. Curre...
Show More Location
Centro Integral Oncologico Clara Campal
Learn More & Join Trial